Search for: "SCHERING-PLOUGH" Results 201 - 220 of 404
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Oct 2010, 7:31 am by David Feldman
Much larger Merck combined with Schering-Plough in a reverse merger last year. [read post]
22 Apr 2008, 5:09 pm
Specific talks of interest include the following: Strategic Considerations for the ANDA Applicant's Pre-Litigation Strategy and Initial Obligations Rethinking Paragraph IV Challenges in View of Shifting Obviousness Standards Litigating with Multiple ANDA Filers: Brand-Name and Generic Perspectives View From the Bench: Judicial Views on Paragraph IV Litigation (with three federal judges on the panel) Mitigating Antitrust Concerns When Settling a Paragraph IV Action Mastering the Interplay… [read post]
10 May 2009, 7:29 pm
" Allowing preferred clients access to work product, showing value delivered beyond the services provided, and honing knowledge capital to a discloseable level of quality, certainly both distinguishes a law firm and benefits a law department (See my post of March 9, 2007: direct access to knowledge base of law firms; and May 17, 2006: Schering-Plough expected its central firms to share work product.). [read post]
3 Oct 2012, 11:00 am by Tom Lamb
Since that time, first, Organon was acquired by Schering-Plough and, later, Merck took over Schering-Plough and Organon. [read post]
1 Jul 2011, 8:23 am by randal shaheen
Schering-Plough, the plaintiff, and manufacturer of Coppertone sunscreen, brought claims for false advertising against Neutrogena. [read post]
12 Aug 2009, 8:09 am
(Spicy IP) UK: Hindsight going forward: taking the risk factor into account: Lilly Icos, Pfizer Enterprises, Merck, AstraZeneca & Ors v 8pm Chemists & Ors (IP finance) US: Gene patenting debate continues – round two (Patent Docs) US: Follow-on biologics news briefs – no 7 (Patent Docs) US: BIO urges Supreme Court to reject rigid Bilski rule (PatentBIOtech) US: Cargill withdraws patent infringement case before ITC against Nantong Foreign Medicines & Health… [read post]
19 May 2011, 12:20 pm by Phil
This case is an antitrust challenge to an agreement settling patent litigation between defendant-appellee Schering-Plough Corp.2 ("Schering") and defendant-appellee Upsher-Smith Laboratories, Inc. [read post]
28 Feb 2011, 6:58 pm by Eric Schweibenz
Organon, which is a wholly owned subsidiary of Merck & Co., Inc. and is related to Organon USA, Inc. and Schering Plough Corporation. [read post]
28 Oct 2014, 6:02 am by Dennis Crouch
When we divide our sample into cases before and after the 2002 Schering-Plough decision, our estimates show that for cases decided after Schering-Plough, the ex ante probability of an ultimate brand victory is 60%, versus just 40% for earlier cases. [read post]
24 Aug 2012, 7:46 pm by Lyle Denniston
   Schering also sued ESI for infringement, but ESI countered that its version was not the same as Schering’s. [read post]
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]